INFbeta therapy for COVID-19 [electronic resource] : the new SNG001 drug / Stephen Holgate.
Material type:
SoundSeries: Henry Stewart talksBiomedical & life sciences collection. Interviews on Covid-19: Publisher: London : Henry Stewart Talks, 2020Description: 1 online resource (1 streaming audio file (10 min.))Other title: INFβ therapy for COVID-19 : the new SNG001 drug | Interferon-beta therapy for COVID-19 : the new SNG001 drugSubject(s): Antiviral agents -- Development | Clinical trials | Coronavirus infections -- Chemotherapy | COVID-19 (Disease) -- Treatment | Interferon | Antiviral Agents -- administration & dosage | Clinical Trials as Topic | Coronavirus infections | COVID-19 -- drug therapy | Drug Delivery Systems | Interferon-beta -- administration & dosage | Interferon-beta -- therapeutic use | Nebulizers and Vaporizers | SARS-CoV-2 | Treatment OutcomeOnline resources: Click here to access online | Series Audio interview.
Title from title frames.
Contents: Why INFβ was chosen as a therapy for COVID-19 -- Previous use of INFβ by inhalation -- Safety of INFβ as a therapy -- SNG001 mode of delivery -- SNG001 clinical trials and future prospects.
Access restricted to subscribers.
Mode of access: World Wide Web.